Skip to main content

Biomedical Advanced Research and Development Authority (BARDA), Biodefense Medical Countermeasure Development

Program Funding
Total Spent
$803.4M
 
Total Obligated
$1.7B

Some agencies choose to report funding totals for multiple programs in a single submission. The obligated and spent totals shown here only reflect those reported for this program alone. To see all money associated with this program, use the All Pandemic Awards dashboard and search for the program in the filter bar.

Number of Awards
121
Assistance Listing
93.360
Published Date
Objectives
The purpose of this program is to coordinate the acceleration of countermeasure and product advanced research and development by??(A) facilitating collaboration between the Department of Health and Human Services and other Federal agencies, relevant industries, academia, and other persons, with respect to such advanced research and development; (B) promoting countermeasure and product advanced research and development; (C) facilitating contacts between interested persons and the offices or employees authorized by the Secretary to advise such persons regarding requirements under the Federal Food, Drug, and Cosmetic Act and under section 351 of the Public Health Service Act; and (D) promoting innovation to reduce the time and cost of countermeasure and product advanced research and development. The Public Health Service Act at 42 U.S.C. 247d-6a defines a qualified countermeasure as ????a…

View the full description on SAM.gov
Total Rows 530